TTM
−$0.38
YoY change
+69.6%
5Y CAGR
—
Peak year (2017)
−$0.19
Latest annual
−$0.39
EPS (Diluted) history chart for Equillium (EQ) from 2017 to 2025
Latest: −$0.39
EPS (Diluted) growth chart for Equillium (EQ) from 2017 to 2025
Latest: +69.6%
EPS (Diluted) history table for Equillium (EQ) from 2017 to 2025
| 2025 | −$0.39 | +69.6% | −$0.16 | ||
| 2024 | −$0.23 | -39.5% | +$0.15 | ||
| 2023 | −$0.38 | -88.1% | +$2.81 | ||
| 2022 | −$3.19 | +136.3% | −$1.84 | ||
| 2021 | −$1.35 | -7.5% | +$0.11 | ||
| 2020 | −$1.46 | -0.7% | +$0.01 | ||
| 2019 | −$1.47 | +34.9% | −$0.38 | ||
| 2018 | −$1.09 | +473.7% | −$0.90 | ||
| 2017 | −$0.19 | — | — |
- 2025−$0.39+69.6%
- 2024−$0.23-39.5%
- 2023−$0.38-88.1%
- 2022−$3.19+136.3%
- 2021−$1.35-7.5%
- 2020−$1.46-0.7%
- 2019−$1.47+34.9%
- 2018−$1.09+473.7%
- 2017−$0.19—
EPS (Diluted) values are taken from Equillium's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Equillium (EQ)
According to Equillium's latest reported financial statements, the company's current diluted EPS (TTM) is −$0.38. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Equillium (EQ) most recent annual diluted EPS stands at −$0.39 (2025) – surged 69.6% year-over-year.
The record annual diluted EPS stands at −$0.19, reached in 2017; the historical low of −$3.19 was recorded in 2022.
Equillium EPS (Diluted) by Year
Equillium EPS (Diluted) 2025: −$0.39
Equillium diluted EPS in 2025 was −$0.39, surged 69.6% from 2024.
Equillium EPS (Diluted) 2024: −$0.23
2024's diluted EPS for Equillium came in at −$0.23, plunged 39.5% below 2023.
Equillium EPS (Diluted) 2023: −$0.38
Equillium posted diluted EPS of −$0.38 in 2023, plunged 88.1% below 2022.
Equillium EPS (Diluted) 2022: −$3.19
In 2022, Equillium reported diluted EPS of −$3.19, surged 136.3% from 2021. This figure represents the lowest annual value in the available history.
Equillium EPS (Diluted) 2021: −$1.35
Equillium diluted EPS in 2021 was −$1.35.
See more financial history for Equillium (EQ). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Equillium (EQ), ranked by their latest diluted EPS
| $22.95 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $3.59 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $3.59
- $2.37
Frequently asked questions
Equillium (EQ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation